HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Kim Selected Research

beta Catenin

1/2001New evidence that nuclear import of endogenous beta-catenin is LEF-1 dependent, while LEF-1 independent import of exogenous beta-catenin leads to nuclear abnormalities.
1/2001Tyrosine phosphorylation translocates beta-catenin from cell-->cell interface to the cytoplasm, but does not significantly enhance the LEF-1-dependent transactivating function.
10/2000Overexpression of beta-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Kim Research Topics

Disease

41Neoplasms (Cancer)
01/2022 - 01/2000
9Breast Neoplasms (Breast Cancer)
01/2018 - 02/2001
6Inflammation (Inflammations)
10/2021 - 10/2001
6Necrosis
12/2017 - 07/2000
6Multiple Myeloma
11/2017 - 11/2010
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016 - 02/2000
5Carcinoma (Carcinomatosis)
07/2013 - 10/2000
4Neoplasm Metastasis (Metastasis)
01/2018 - 08/2004
4Stomach Neoplasms (Stomach Cancer)
01/2018 - 09/2003
4Lung Neoplasms (Lung Cancer)
07/2012 - 02/2001
3Fibrosis (Cirrhosis)
10/2021 - 06/2001
3Pain (Aches)
01/2021 - 01/2018
3Infections
09/2020 - 02/2001
3Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2015 - 02/2009
3Autoimmune Diseases (Autoimmune Disease)
11/2013 - 05/2008
3Carcinogenesis
07/2013 - 01/2001
3Hepatocellular Carcinoma (Hepatoma)
07/2012 - 06/2001
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2010 - 04/2001
2Cholangiocarcinoma
01/2022 - 10/2015
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 03/2013
2Disease Progression
01/2018 - 10/2017
2Melanoma (Melanoma, Malignant)
10/2017 - 06/2001
2Adenocarcinoma
09/2017 - 05/2005
2Cardiovascular Diseases (Cardiovascular Disease)
01/2017 - 02/2000
2Epilepsy (Aura)
01/2017 - 08/2016
2Hematologic Neoplasms (Hematological Malignancy)
10/2014 - 11/2010
2Hypoxia (Hypoxemia)
03/2014 - 12/2008
2Ovarian Neoplasms (Ovarian Cancer)
07/2013 - 06/2013
2Esophageal Squamous Cell Carcinoma
04/2013 - 09/2010
2Overweight
08/2012 - 09/2008
2Thrombosis (Thrombus)
05/2012 - 02/2001
2Graft vs Host Disease (Graft-Versus-Host Disease)
11/2010 - 11/2003
2Tuberculosis (Tuberculoses)
06/2010 - 01/2007
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
02/2009 - 12/2005
2T-Cell Lymphoma (Lymphoma, T Cell)
12/2008 - 04/2005
2Acromegaly
06/2001 - 03/2001
2Pituitary Neoplasms (Pituitary Adenoma)
06/2001 - 03/2001
2Prolactinoma (Prolactinomas)
06/2001 - 03/2001

Drug/Important Bio-Agent (IBA)

9Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2010
8Proteins (Proteins, Gene)FDA Link
01/2020 - 11/2000
8CytokinesIBA
09/2017 - 01/2000
5Messenger RNA (mRNA)IBA
10/2021 - 02/2001
5Peptides (Polypeptides)IBA
05/2013 - 06/2001
5RNA (Ribonucleic Acid)IBA
09/2008 - 03/2001
4Capecitabine (Xeloda)FDA Link
01/2018 - 01/2004
4DNA (Deoxyribonucleic Acid)IBA
12/2017 - 02/2000
4CaspasesIBA
10/2014 - 01/2000
4Cisplatin (Platino)FDA LinkGeneric
09/2010 - 02/2000
4LigandsIBA
05/2008 - 02/2000
3MicroRNAs (MicroRNA)IBA
06/2021 - 02/2012
3Hormones (Hormone)IBA
01/2020 - 03/2001
3Interferon-gamma (Interferon, gamma)IBA
09/2014 - 11/2003
3Paclitaxel (Taxol)FDA LinkGeneric
07/2013 - 02/2000
3AnthracyclinesIBA
03/2013 - 01/2004
3taxaneIBA
03/2013 - 01/2004
3Interleukin-2 (IL2)IBA
06/2001 - 07/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2001 - 02/2000
3beta CateninIBA
01/2001 - 10/2000
2hydroxide ionIBA
01/2021 - 01/2020
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2018 - 03/2013
2Bortezomib (Velcade)FDA Link
11/2017 - 12/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 08/2016
2AutoantibodiesIBA
01/2016 - 02/2001
2SteroidsIBA
10/2014 - 12/2008
2Tuberculin (PPD)IBA
09/2014 - 06/2010
2AntigensIBA
09/2014 - 06/2001
2InterleukinsIBA
09/2014 - 10/2012
2Ligases (Synthetase)IBA
03/2014 - 09/2000
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
03/2013 - 03/2011
2Interleukin-6 (Interleukin 6)IBA
10/2012 - 07/2012
2Pharmaceutical PreparationsIBA
10/2012 - 01/2003
2Metalloproteases (Metalloproteinases)IBA
07/2012 - 01/2003
2Fluorouracil (Carac)FDA LinkGeneric
05/2012 - 05/2005
2ElementsIBA
12/2011 - 09/2011
2Methotrexate (Mexate)FDA LinkGeneric
11/2010 - 12/2005
2fludarabineIBA
11/2010 - 04/2001
2Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2010 - 11/2003
2Doxorubicin (Adriamycin)FDA LinkGeneric
12/2008 - 02/2000
2Death Domain ReceptorsIBA
05/2008 - 05/2000
2Etoposide (VP 16)FDA LinkGeneric
12/2005 - 02/2000
2Caspase 9IBA
05/2004 - 11/2000
2Liposomes (Liposome)IBA
06/2001 - 10/2000

Therapy/Procedure

16Therapeutics
01/2018 - 01/2000
14Drug Therapy (Chemotherapy)
03/2013 - 02/2000
6Radiotherapy
08/2015 - 05/2012
5Neoadjuvant Therapy
01/2022 - 04/2011
4Injections
10/2021 - 04/2001
4Hematopoietic Stem Cell Transplantation
10/2011 - 01/2002
3Adjuvant Chemoradiotherapy
09/2017 - 05/2012
3Hysterectomy
11/2015 - 09/2011
3Chemoradiotherapy
09/2013 - 09/2003
3Lymph Node Excision (Lymph Node Dissection)
04/2013 - 09/2003
3Combination Drug Therapy (Combination Chemotherapy)
09/2010 - 07/2004
2Decompression
04/2022 - 03/2008
2Pancreaticoduodenectomy
01/2022 - 09/2013
2Curettage
11/2015 - 07/2010
2Adjuvant Radiotherapy
10/2015 - 05/2012
2Transplantation
11/2014 - 05/2006
2Artificial Respiration (Mechanical Ventilation)
01/2009 - 05/2008
2Stem Cell Transplantation
05/2006 - 12/2005